Active surveillance provides an important alternative to immediate treatment for early-stage, low-ri Investigators from the phase 3 ARAMIS trial reported a significant delay in PSA progression in ...
Prostate cancer (PCa) is one of the most common malignant tumors among men worldwide. Following androgen deprivation therapy ...
Expert perspectives on the treatment approach for patients with metastatic castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD ...
Accuracy of a simplified sequencing and bioinformatics platform on genetic variant detection in patients with prostate cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results